Chemotherapy toxicity and quality of life in older women with advanced or recurrent endometrial cancer: An NRG Oncology - Gynecologic Oncology Group ancillary study

被引：0
|
作者：
Ko, E. M. [1 ]
Java, J. [2 ]
Van Le, L. [3 ]
Schmitz, K. [4 ]
Randall, M. E. [5 ]
Bloss, J. D. [6 ]
Fleming, G. [7 ]
Moore, D. H. [8 ]
Monk, B. J. [9 ]
Muss, H. B. [10 ]
机构：
[1] Univ Penn, Philadelphia, PA 19104 USA
[2] Gynecol Oncol Grp, Stat & Data Ctr, Buffalo, NY USA
[3] Univ N Carolina, Chapel Hill, NC USA
[4] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA
[5] Univ Kentucky, Med Ctr, Lexington, KY USA
[6] Astella Pharma, Northbrook, IL USA
[7] Univ Chicago, Med Ctr, Chicago, IL 60637 USA
[8] Franciscan Phys Network Gynecol Oncol Specialists, Indianapolis, IN USA
[9] Univ Arizona, Ctr Canc, Phoenix, AZ USA
[10] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC USA
来源：
GYNECOLOGIC ONCOLOGY | 2015年 / 137卷
关键词：
D O I：
10.1016/j.ygyno.2015.01.075
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
73
引用
收藏
页码：32 / 32
页数：1
相关论文
共 50 条
  • [31] Surgical outcomes among elderly women with endometrial cancer treated by laparoscopic hysterectomy: a NRG/Gynecologic Oncology Group study
    Bishop, Erin A.
    Java, James J.
    Moore, Kathleen N.
    Spirtos, Nick M.
    Pearl, Michael L.
    Zivanovic, Oliver
    Kushner, David M.
    Backes, Floor
    Hamilton, Chad A.
    Geller, Melissa A.
    Hurteau, Jean
    Mathews, Cara
    Wenham, Robert M.
    Ramirez, Pedro T.
    Zweizig, Susan
    Walker, Joan L.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2018, 218 (01) : 109.e1 - 109.e11
  • [32] Quality of life of older gynecologic oncology patients at the initiation of chemotherapy
    Kleven, Anne Grethe
    Miaskowski, Christine
    Torstveit, Ann Helen
    Ritchie, Christine Seel
    Engh, Marie Ellstrom
    Andersen, Elin
    Utne, Inger
    NURSING OPEN, 2023, 10 (10): : 6749 - 6757
  • [33] Neurotoxicity in ovarian cancer patients on Gynecologic Oncology Group (GOG) protocol 218: Characteristics associated with toxicity and the effect of substitution with docetaxel: An NRG Oncology/Gynecologic Oncology Group study
    Chase, Dana M.
    Huang, Helen
    Foss, Cassandra D.
    Wenzel, Lari B.
    Monk, Bradley J.
    Burger, Robert A.
    GYNECOLOGIC ONCOLOGY, 2015, 136 (02) : 323 - 327
  • [34] Predictive biomarkers of endometrial cancer response: Results from NRG Oncology/Gynecologic Oncology Group study 86P
    Levine, D. A.
    Dizon, D. S.
    Carlson, J. W.
    Filiaci, V. L.
    Powell, M. A.
    Secord, A. A.
    Tewari, K. S.
    Bender, D. P.
    O'Malley, D. M.
    Stuckey, A. R.
    Moore, K. N.
    Dewdney, S. B.
    Gao, J.
    Dao, F.
    Soslow, R. A.
    Lankes, H. A.
    Aghajanian, C. A.
    GYNECOLOGIC ONCOLOGY, 2018, 149 : 12 - 13
  • [35] Impact of smoking on survival among women treated with and without bevacizumab for advanced cervical cancer (CxCA): An NRG Oncology/Gynecologic Oncology Group study
    Waggoner, S. E.
    Java, J.
    Monk, B. J.
    Michael, H.
    Penson, R. T.
    Leitao, M. M.
    Coleman, R. L.
    Mannel, R. S.
    Oaknin, A.
    Tewari, K. S.
    GYNECOLOGIC ONCOLOGY, 2015, 137 : 143 - 144
  • [36] FGFR2 mutations are associated with poor outcomes in endometrioid endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study
    Jeske, Yvette W.
    Ali, Shamshad
    Byron, Sara A.
    Gao, Feng
    Mannel, Robert S.
    Ghebre, Rahel G.
    DiSilvestro, Paul A.
    Lele, Shashikant B.
    Pearl, Michael L.
    Schmidt, Amy P.
    Lankes, Heather A.
    Ramirez, Nilsa C.
    Rasty, Golnar
    Powell, Matthew
    Goodfellow, Paul J.
    Pollock, Pamela M.
    GYNECOLOGIC ONCOLOGY, 2017, 145 (02) : 366 - 373
  • [37] Prognostic significance of ethnicity and age in advanced stage epithelial ovarian cancer: An NRG oncology/gynecologic oncology group study
    DuPont, Nefertiti C.
    Enserro, Danielle
    Brady, Mark F.
    Moxley, Katherine
    Walker, Joan L.
    Cosgrove, Casey
    Bixel, Kristin
    Tewari, Krishnansu S.
    Thaker, Premal
    Hendrickson, Andrea E. Wahner
    Rubin, Stephen
    Fujiwara, Keiichi
    Casey, A. Catherine
    Soper, John
    Burger, Robert A.
    Monk, Bradley J.
    GYNECOLOGIC ONCOLOGY, 2022, 164 (02) : 398 - 405
  • [38] Factors Associated With Grade 3 or 4 Treatment-Related Toxicity in Women With Advanced or Recurrent Cervical Cancer An Exploratory Analysis of NRG Oncology/Gynecologic Oncology Group Trials 179 and 204
    Chase, Dana M.
    Kauderer, James
    Wenzel, Lari
    Ramondetta, Lois
    Cella, David
    Long, Harry J., III
    Monk, Bradley J.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (02) : 303 - 308
  • [39] Pathologic and Treatment Outcomes Among a Geriatric Population of Endometrial Cancer Patients: An NRG Oncology/Gynecologic Oncology Group Ancillary Data Analysis of LAP2
    Bishop, Erin A.
    Java, James J.
    Moore, Kathleen N.
    Walker, Joan L.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 (04) : 730 - 737
  • [40] Phase II evaluation of dalantercept in the treatment of persistent or recurrent epithelial ovarian cancer: An NRG Oncology/Gynecologic Oncology Group study
    Burger, Robert A.
    Deng, Wei
    Makker, Vicky
    Collins, Yvonne
    Gray, Heidi
    Debernardo, Robert
    Martin, Lainie P.
    Aghajanian, Carol
    GYNECOLOGIC ONCOLOGY, 2018, 150 (03) : 466 - 470
12345